EEOICPA BULLETIN NO.06-03
Issue
Date:
________________________________________________________________
Effective
Date:
________________________________________________________________
Expiration
Date:
________________________________________________________________
NOTE: This bulletin replaces Bulletin 05-03, Processing Claims for
Mallinckrodt Chemical Works,
Subject: Processing Claims
for Mallinckrodt Chemical Works,
Background: Pursuant to the Energy Employees Occupational
Illness Compensation Program Act of 2000 (EEOICPA) and 42 C.F.R. Part 83, a
petition was filed on behalf of a class of workers from the Uranium Division of Mallinckrodt Chemical Works, Destrehan
Street Facility, St.
The National Institute for
Occupational Safety and Health (NIOSH) reviewed the petition and decided it qualified
for evaluation under 42 C.F.R. Part § 83.13.
NIOSH submitted its findings to the petitioners and the Advisory Board
on Radiation and Worker Health (“the Board”). On
On
Employees
of the Department of Energy (DOE) or DOE contractors or subcontractors employed
by the Uranium Division of Mallinckrodt Chemical Works, Destrehan Street
Facility, during the period from 1942 through 1948 and who were employed for a
number of work days aggregating at least 250 work days either solely under this
employment or in combination with work days within the parameters (excluding
aggregate work day requirements) established for other classes of employees
included in the SEC.
In their evaluation, NIOSH
determined that, “… it lacks access to sufficient information to either
estimate the maximum radiation dose for every type of cancer for which
radiation doses are reconstructed that could have been incurred under plausible
circumstances by any member of the class, or to estimate the radiation doses of
members of the class more precisely than a maximum dose estimate.” In other words, NIOSH has indicated that it
is not feasible to undertake dose reconstructions for the class of employees
employed at the Mallinckrodt Chemical Works for the
period from 1942 through 1948. In
view of HHS’ explanation of the rationale for designating this class of
employees as members of the SEC, HHS has determined that NIOSH cannot perform
dose reconstructions for any cases, i.e., cases with either specified or
non-specified cancers.
References: Energy Employees
Occupational Illness Compensation Act of 2000, 42 U.S.C. § 7384 et seq.; 42 C.F.R. Part 83, Procedures
for Designating Classes of Employees as Members of the Special Exposure Cohort
Under EEOICPA; and the April 11, 2005 report to Congress from the Secretary of
HHS, entitled, “HHS Designation of Additional Members of the Special Exposure
Cohort, Designating a Class of Employees from Uranium
Division of Mallinckrodt Chemical Works, Destrehan Street Facility, St. Louis,
Missouri.”
Purpose: To provide procedures for
processing claims for the new SEC class at the Mallinckrodt
Chemical Works, Destrehan Street Facility. The new SEC class applies to DOE employees, DOE
contractors or subcontractors employed by Mallinckrodt
Chemical, during the period from 1942 through 1948 and who were employed
for a number of work days aggregating at least 250 work days either solely
under this employment or in combination with work days within the parameters established
for other classes of employees included in the SEC.
Applicability: All staff.
Actions:
1. The consideration of DOE employees, DOE contractors
or subcontractors employed by the Mallinckrodt Chemical
Works, Destrehan Street Facility, during the period from 1942 through 1948 encompasses
claims already denied, claims at NIOSH for dose reconstruction, and future
claims yet to be submitted. The DEEOIC has identified
all Part B claims that were denied or are at NIOSH for dose reconstruction and
submitted a list of cases to the appropriate district office. NIOSH will send a CD for each case with all
information generated to date, e.g., CATI report, correspondence, and dose
information. Also, included on the CD in
the Correspondence Folder should be a copy of the NIOSH letter sent to each
claimant informing them of the new SEC class and that their case is being
returned to DOL for adjudication. The claims
examiner (CE)
must print out a hard copy of the NIOSH letter for inclusion in the case
file.
2. When a case on the list is
returned from NIOSH, a previously denied claim is reopened, a claim is remanded
by FAB, or a new claim for compensation is submitted, the CE reviews the
documentation submitted with the EE-1
or EE-2 and EE-3 forms. Development of medical and employment
information should proceed in the usual manner.
If the evidence is unclear as to whether employment falls within the new
SEC class time period, the claimant should be asked to provide clarification. The CE must review any
documentation submitted by the claimant and undertake any additional development
necessary to
clarify the individual’s medical and employment status.
3. Based on
this review, the CE determines whether the claimant has a specified cancer, as
listed in DEEOIC Procedure Manual Chapter 2-600.5. If the employee has a specified cancer,
proceed to the next step. If the
employee does not have a specified cancer, proceed to step #6.
4. The CE must verify that the employee worked
for the DOE or a DOE contractor or subcontractor
employed by the Uranium Division of Mallinckrodt Chemical Works at the
5. Once the CE has determined
that the person named in the claim has a diagnosed specified cancer and meets the
employment criteria of the SEC class, the CE should proceed in the usual manner for a compensable claim and
prepare a recommended decision.
6. As discussed earlier, HHS
has determined that NIOSH cannot perform dose reconstructions for any cases,
i.e., cases with either specified or non-specified cancers. If the CE has determined that the person
named in the claim has a non-specified cancer or does not meet the employment
criteria of the SEC class, the CE should
proceed in the usual manner for a denied claim and prepare a
recommended decision. However, HHS is
considering the SEC petition for the period of 1949 to 1957 for the Mallinckrodt
Chemical Works. If
any employment is present for this period, the CE must delay the decision to
deny pending the HHS’ decision.
7. If the claim includes both a specified cancer and
a non-specified cancer, medical benefits are only paid for the specified
cancer(s) and any secondary cancers that are metastases of the specified
cancer(s). Again, this is based on the
HHS determination that NIOSH
cannot perform dose reconstructions for any cases.
8. If a case on the list meets the SEC class
criteria, but has a denied final decision, the CE must submit the case for
reopening through the appropriate process in the district office. The case must be forwarded to the DEEOIC
Director to reopen the claim per 20 C.F.R. § 30.320.
9. FAB personnel must be vigilant for any cases from
the Mallinckrodt
Chemical Works at the
Disposition:
Retain until incorporated in the Federal (EEOICPA) Procedure Manual.
PETER
M. TURCIC
Director,
Division of Energy Employees
Occupational
Illness Compensation
Distribution
List No. 1: Claims Examiners, Supervisory Claims Examiners, Technical
Assistants, Customer Service Representatives, Fiscal Officers, FAB District
Managers, Operation Chiefs, Hearing Representatives, and District Office Mail
& File Sections